Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.885
+0.065 (3.57%)
Jul 17, 2025, 3:51 PM - Market open

Mainz Biomed Stock Forecast

MYNZ's stock price has decreased by -88.94% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Mainz Biomed stock have an average target of 14, which predicts a 642.71% increase from the current stock price of 1.89.

Price Target: $14 (+642.71%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$14$14$14$14
Change+642.71%+642.71%+642.71%+642.71%
* Price targets were last updated on Feb 14, 2025.

Analyst Ratings

The average analyst rating for Mainz Biomed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy000000
Hold222221
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Initiates
$14
Strong BuyInitiates$14+642.71%Feb 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aNov 25, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Reiterates
n/a
HoldReiteratesn/an/aApr 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$200$120
Strong BuyMaintains$200$120+6,266.05%Mar 6, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgrades
n/a
HoldDowngradesn/an/aNov 21, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
1.13M
from 893.99K
Increased by 26.06%
Revenue Next Year
1.18M
from 1.13M
Increased by 4.97%
EPS This Year
-3.98
from -22.36
EPS Next Year
-1.92
from -3.98
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
493.57K577.35K529.88K895.48K893.99K1.13M1.18M2.80M
Revenue Growth
75.40%16.98%-8.22%69.00%-0.17%26.06%4.97%136.77%
EPS
-4.19-64.85-74.55-64.76-22.36-3.98-1.92-2.03
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High1.2M1.2M2.9M
Avg1.1M1.2M2.8M
Low1.1M1.1M2.7M

Revenue Growth

Revenue Growth20252026202720282029
High
29.8%
8.1%
143.7%
Avg
26.1%
5.0%
136.8%
Low
21.1%
0.9%
127.5%

EPS Forecast

EPS202520262027
High-4.10-1.97-2.09
Avg-3.98-1.92-2.03
Low-3.82-1.84-1.95

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.